BIO-RAD LABORATORIES, INC. - Common Stock (BIO)

Historical Holders from Q1 2014 to Q1 2025

Symbol
BIO on NYSE
CUSIP
090572207
Type / Class
Equity / Common Stock
Shares outstanding
22.8M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
18.8M
Holdings value
$6.16B
% of all portfolios
0.01%
Grand Portfolio weight change
0%
Number of holders
442
Number of buys
200
Number of sells
-195
Average Value change %
0%
Average buys %
+0.002%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BIO-RAD LABORATORIES, INC. - Common Stock (BIO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 8.37% $465M 1.91M The Vanguard Group - 23-1945930 Sep 30, 2024

Institutional Holders of BIO-RAD LABORATORIES, INC. - Common Stock (BIO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 164K $40M -$32.4M $243.56 55
2024 Q4 18.8M $6.16B -$152M $328.51 442
2024 Q3 19.2M $6.41B -$280M $334.58 427
2024 Q2 19.8M $5.41B +$464M $273.11 426
2024 Q1 18.3M $6.32B -$35.4M $345.87 456
2023 Q4 18.2M $5.87B -$38M $322.89 464
2023 Q3 18.5M $6.61B -$70.1M $358.45 456
2023 Q2 17.8M $6.76B -$278M $379.12 453
2023 Q1 19M $9.09B +$18.9M $479.02 489
2022 Q4 19M $8.01B -$128M $420.49 459
2022 Q3 19.4M $8.1B +$130M $417.14 463
2022 Q2 19.1M $9.43B +$17.4M $495.00 482
2022 Q1 19.1M $10.7B -$18.7M $563.23 494
2021 Q4 19M $14.3B -$402M $755.57 509
2021 Q3 18.9M $14.1B -$123M $745.95 492
2021 Q2 17.7M $11.4B -$227M $644.29 495
2021 Q1 19.5M $11.1B -$15.4M $571.17 476
2020 Q4 19.6M $11.4B +$294M $582.94 477
2020 Q3 18.8M $9.71B +$5.82M $515.46 465
2020 Q2 19.2M $8.66B +$190M $451.49 455
2020 Q1 18.8M $6.59B -$7.55M $350.56 393
2019 Q4 18.9M $6.99B -$71.2M $370.03 373
2019 Q3 19.2M $6.39B +$145M $332.74 343
2019 Q2 18.6M $5.82B -$97.2M $312.59 321
2019 Q1 19.4M $5.92B +$30.2M $305.68 336
2018 Q4 18.5M $4.3B -$58.6M $232.22 313
2018 Q3 18.9M $5.92B +$12.4M $312.99 333
2018 Q2 19.1M $5.51B -$8.92M $288.54 316
2018 Q1 19.3M $4.81B +$32M $250.08 304
2017 Q4 19.2M $4.58B +$6.46M $238.67 294
2017 Q3 19.2M $4.26B +$85M $222.22 269
2017 Q2 18.8M $4.26B -$43.9M $226.31 274
2017 Q1 19M $3.8B +$211M $199.34 268
2016 Q4 19.7M $3.59B +$100M $182.28 250
2016 Q3 19.1M $3.12B +$559K $163.81 232
2016 Q2 18.8M $2.69B +$67.6M $143.02 229
2016 Q1 18.3M $2.5B -$30.8M $136.72 225
2015 Q4 18.3M $2.53B -$10.8M $138.66 232
2015 Q3 18.7M $2.51B +$20.7M $134.31 239
2015 Q2 18.4M $2.78B -$14M $150.61 219
2015 Q1 18.8M $2.55B +$11.1M $135.18 212
2014 Q4 18.8M $2.27B +$17.4M $120.56 210
2014 Q3 18.4M $2.09B +$35.4M $113.40 198
2014 Q2 18.3M $2.19B +$17.3M $119.71 201
2014 Q1 18.1M $2.31B -$21.5M $128.12 188